Skip to main content
SpringerLink
Log in

Corpus uteri

  • Chapter
Die Gynäkologie

Zusammenfassung

Die Ätiologie ist unklar, evtl. kommen hormonelle Dysbalancen für die Hyperplasie des Endometriums infrage. Dafür spricht das bevorzugte Auftreten in der Peri- und Postmenopause, wobei in der Postmenopause unbedingt ein Endometriumkarzinom ausgeschlossen werden muss. Nicht selten treten Korpuspolypen und Endometriumkarzinome gemeinsam auf. Differenzialdiagnostisch kommen weiterhin Uterusmyome in Betracht.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ackerman IS, Malone G, Thomas E, Franssen J, Dembo A (1996) Endometrial carcinoma-relative effectiveness of adjuvant irradiation vs therapy reserved for relapse [see comments]. Gynecol Oncol 60 (2): 177–183

    Article  PubMed  CAS  Google Scholar 

  • Assikis VJ, Bilimoria MM, Muenzner HD et al. (1996) Mutations of the estrogen receptor in endometrial carcinoma: evidence of an association with high tumor grade

    Google Scholar 

  • Ball HG, Blessing JA, Lentz SS, Mutch DG (1996) A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 62 (2): 278–281

    Article  PubMed  CAS  Google Scholar 

  • Blumenfeld ML, Turner LP (1996) Role of transvaginal sonography in the evaluation of endometrial hyperplasia and cancer. Clin Obstet Gynecol 39 (3): 641–655

    Article  PubMed  CAS  Google Scholar 

  • Blythe JG, Edwards E, Heimbecker P (1997) Paraaortic lymph node biopsy: a twenty-year study. Am J Obstet Gynecol 176: 1157–1165

    Article  PubMed  CAS  Google Scholar 

  • Cecchini S, Ciatto S, Bonardi R. (1996) Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen

    Google Scholar 

  • Clement PB, Oliva E, Young RH (1996) Mullerian adenosarcoma of the uterine corpus associated with tamoxifen therapy: a report of six cases and a review of tamoxifen-associated endometrial lesions. Int J Gynecol Pathol 15 (3): 222–229

    Article  PubMed  CAS  Google Scholar 

  • Covens A, Thomas G, Shaw P et al. (1997) A phase II study of leuprolide in advanced/recurrent endometrial cancer. Gyne-col Oncol 64 (1): 126–129

    Article  CAS  Google Scholar 

  • Douchi T, Ijuin H, Nakamura S. (1997) Correlation of body fat distribution with grade of endometrial cancer

    Google Scholar 

  • Fedele L, Bianchi S, Raffaelli R, Zanconato G (2000) A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas. Eur J Obstet Gynecol Reprod Biol 88 (1): 91–94

    Article  PubMed  CAS  Google Scholar 

  • Filicori M, Hall DA, Loughlin JS et al (1983) A conservative approach to the management of uterine leiomyoma: Pituitary desensitization by a luteinizing hormone-releasing hormone analogue. Am J Obstet Gynecol 147: 726–727

    Google Scholar 

  • Fishman DA, Roberts KB, Chambers JT, Kohorn EI, Schwartz PE, Chambers SK (1996) Radiation therapy as exclusive treatment for medically patients with stage I and II endometrioid carcinoma of the endometrium. Gynecol Oncol 61: 189–196

    Article  PubMed  CAS  Google Scholar 

  • Fowler JM (1996) Laparoscopic staging of endometrial cancer. Clin Obstet Gynecol 39 (3): 669–685

    Article  PubMed  CAS  Google Scholar 

  • Gallinat A, Lueken RP (1993) Addendum-current trends in the therapy of myomata. In: Lueken RP, Gallinat A (eds) Endoscopic Surgery in Gynecology. Hamburg: Demeter Verlag GmbH: 69

    Google Scholar 

  • Gebhard C (1899) Veit’s Handbuch der Gynäkologie 2: 439 Goodman A, Zukerberg LR, Rice LW, Fuller AF, Young RH, Scully RE (1996) Squamous cell carcinoma of the endometrium: a report of eight cases and a review of the literature. Gynecol Oncol 61 (1): 54–60

    Google Scholar 

  • Gretz HF rd, Economos K, Husain A et al. (1996) The practice of surgical staging and its impact on adjuvant treatment recommendations in patients with stage I endometrial carcinoma. Gynecol Oncol 61 (3): 409–415

    Article  Google Scholar 

  • Hamel NW, Sebo TJ,Wilson TO et al. (1996) Prognostic value of P53 and proliferating cell nuclear antigen expression in endometrial carcinoma. Gynecol Oncol 62 (2): 192–198

    Article  PubMed  CAS  Google Scholar 

  • Hill HA, Eley JW, Harlan LC, Greenberg RS, Barrett RJ 2nd, Chen VW (1996) Racial differences in endometrial cancer survival: the black/white cancer survival study. Obstet Gynecol 88 (6): 919–926

    Article  PubMed  CAS  Google Scholar 

  • Jeyarajah AR, Gallagher CJ, Blake PR, Oram DH, Dowsett M, Fisher C, Oliver RT (1996) Long-term follow-up of gonadotrophin-releasing hormone analog treatment for recurrent endometrial cancer. Gynecol Oncol 63 (1): 47–52

    Article  PubMed  CAS  Google Scholar 

  • Kaku T, Tsukamoto N, Hachisuga T et al. (1996) Endometrial carcinoma associated with hyperplasia. Gynecol Oncol 60 (1): 22–25

    Article  PubMed  CAS  Google Scholar 

  • Kim YB, Holschneider CH, Ghosh K, Nieberg RK, Montz FJ (1997) Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature. Cancer 79 (2): 320–327

    Article  PubMed  CAS  Google Scholar 

  • Knocke TH, Kucera H, Weidinger B. (1997) Primary treatment of endometrial carcinoma with high-dose-rate brachytherapy: results of 12 years of experience with 280 patients

    Google Scholar 

  • Kohler MF, Carney P, Dodge R. (1996) p53 overexpression in advanced-stage endometrial adenocarcinoma

    Google Scholar 

  • Lentz SS, Brady MF, Major FJ, Reid GC, Soper JT (1996) High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 14 (2): 357–361

    PubMed  CAS  Google Scholar 

  • Li TC, Mortimer R, Cooke ID (1999) Myomectomy: a retrospective study to examine reproductive performance before and after surgery. Hum Reprod 14 (7): 1735–1740

    Article  PubMed  CAS  Google Scholar 

  • Morris M, Alvarez RD, Kinney WK, Wilson TO (1996) Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration. Gynecol Oncol 60 (2): 288–291

    Article  PubMed  CAS  Google Scholar 

  • Nag S (1996) Modern techniques of radiation therapy for endometrial cancer. Clin Obstet Gynecol 39 (3): 728–744

    Article  PubMed  CAS  Google Scholar 

  • Nicklin JL, Copeland LJ (1996) Endometrial papillary serous carcinoma: patterns of spread and treatment. Clin Obstet Gynecol 39 (3): 686–695

    Article  PubMed  CAS  Google Scholar 

  • Orr JW Jr, Holimon JL, Orr PF (1997) Stage I corpus cancer: is teletherapy necessary? Am J Obstet Gynecol 176 (4): 777–788

    Article  PubMed  Google Scholar 

  • Orr JW Jr., Orr PF, Taylor PT (1996) Surgical staging endome-trial cancer. Clin Obstet Gynecol 39 (3): 656–668

    Article  PubMed  Google Scholar 

  • Partridge EE, Shingleton HM, Menck HR, Partridge EE, Shingleton HM, Menck HR (1996) The National Cancer Data Base report on endometrial cancer

    Google Scholar 

  • Plaxe SC, Saltzstein SL, Elliott EA, Matanoski GM, Rosenshein NB, Grumbine FC, Diamond EL (1997) Impact of ethnicity on the incidence of high-risk endometrial carcinoma

    Google Scholar 

  • Schorge JO, Molpus KL, Goodman A,Nikrui N, Fuller AF (1996) The effect of postsurgical therapy on stage III endometrial carcinoma. Gynecol Oncol 63: 34–39

    CAS  Google Scholar 

  • Shumsky AG, Brasher PM, Stuart GC et al. (1997) Risk-specific follow-up for endometrial carcinoma patients

    Google Scholar 

  • Sutton GP, Blessing JA, DeMars RL, Moore D, Burke TW, Grendys EC (1996) A phase II Gynecologic Oncology Group trial of ifosfamide and mesna in advanced or recurrent adenocarcinoma of the endometrium. Gynecol Oncol 63 (1): 25–27

    Article  PubMed  CAS  Google Scholar 

  • Taylor HB, Norris HJ (1966) Mesenchymal tumors of the uterus: IV. Diagnosis and prognosis of leiomyosarcomas. Arch Pathol 82: 40

    Google Scholar 

  • Tepper R, Beyth Y, Altaras MM, Zalel Y, Shapira J, Cordoba M, Cohen I (1997) Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients. Gynecol Oncol 64 (3): 386–391

    Article  PubMed  CAS  Google Scholar 

  • Yokoyama Y, Maruyama H, Sato S, Saito Y (1997) Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. Gynecol Oncol 64: 411–417

    Article  PubMed  CAS  Google Scholar 

  • Zreik. (1998) J Am Assoc Gynecol Laparoscopy: 33–38

    Google Scholar 

Download references

Authors
  1. V. Hanf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Kreienberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Gynäkologie und Geburtshilfe, Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, D-60590, Frankfurt, Deutschland

    Manfred Kaufmann

  2. Frauenklinik Markus-Krankenhaus, Wilhelm-Epstein-Str. 2, D-60431, Frankfurt, Deutschland

    Serban D. Costa

  3. Klinikum St. Marien Amberg, Frauenklinik, Mariahilfbergweg 7, D-92211, Amberg, Deutschland

    Anton Scharl

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hanf, V., Kreienberg, R. (2003). Corpus uteri. In: Kaufmann, M., Costa, S.D., Scharl, A. (eds) Die Gynäkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-11496-4_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-11496-4_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-11497-1

  • Online ISBN: 978-3-662-11496-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation